Hepatitis C Treatment Market By Drug Type (Interferons, Ribavirin, Direct-Acting Antivirals (DAA) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025
A hepatitis C is inflammatory disease of the liver caused by infection with hepatitis C virus (HCV). Increasing prevalence hepatitis C, improved diagnostic techniques, easy availability of treatment medication and strong presence of pipeline molecules are driving the growth of hepatitis C treatment market globally.
The report titled “Hepatitis C treatment Market - Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall hepatitis C treatment market along with the market size and estimates for the duration 2015 to 2025. The research study covers in-depth analysis of market segments based on drug type and different geographical regions. Geographically, the global hepatitis C treatment market is studied for the following regional markets:
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Rest of Europe
- Asia-Pacific
- China
- Japan
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of LATAM
- Middle East and Africa
- GCC
- Rest of MEA
Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2017-2025 are also included in this report, considering 2016 as the base year.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global hepatitis C treatment market. In depth analysis of pipeline molecule for key products hepatitis C treatment, global epidemiology data for hepatitis C have been included in report. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global hepatitis C treatment market. This report concludes with company profiles section that highlights major information about the key players engaged in global hepatitis C treatment market. In-depth competitive environment analysis and historical years (2015) market size data are also provided in the report.
Thus, the research study provides a holistic view of the global hepatitis C treatment market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
2.1 Global Hepatitis C Treatment Market Snapshot
2.2 Global Hepatitis C Treatment Market, by Drug Type
2.3 Global Hepatitis C Treatment Market Share, by Geography, 2016 (Value %)
Chapter 3 Hepatitis C Treatment Market Analysis
3.1 Global Hepatitis C Treatment Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Pipeline Analysis of Hepatitis C Treatment Drugs
3.4 Global Epidemiology of Hepatitis C
3.5 Attractive Investment Proposition
3.6 Competitive Landscape of Key Players in Hepatitis C Treatment Market
Chapter 4 Global Hepatitis C Treatment Market, by Drug Type
4.1 Overview
4.2 Attractive Investment Proposition: Global Hepatitis C Treatment Market, by Drug Type
4.3 Top 3 Countries
4.4 Interferons
4.4.1 Peginterferon alfa-2a
4.4.2 Peginterferon alfa-2b
4.4.3 Interferon alfa-2b
4.5 Ribavirin
4.6 Direct-Acting Antivirals (DAA)
4.6.1 Protease Inhibitor (Paritaprevir, Simepravir, Grazoprevir)
4.6.2 Polymerase Inhibitors
4.6.3 Other Drugs
Chapter 5 Global Hepatitis C Treatment Market, By Geography
5.1 Preface
5.2 North America (U.S. & Canada)
5.2.1 North America Hepatitis C Treatment Market, by Drug Type, 2015- 2025 (US$)
5.2.2 North America Hepatitis C Treatment Market, by Country, 2015- 2025 (US$)
5.3 Europe (U.K., Germany & Rest of Europe)
5.3.1 Europe Hepatitis C Treatment Market, by Drug Type, 2015- 2025 (US$)
5.3.2 Europe Hepatitis C Treatment Market, by Country, 2015- 2025 (US$)
5.4 Asia Pacific (China, Japan and Rest of APAC)
5.4.1 Asia Pacific Hepatitis C Treatment Market, by Drug Type, 2015- 2025 (US$)
5.4.1 Asia Pacific Hepatitis C Treatment Market, by Country, 2015- 2025 (US$)
5.5 Latin America (Brazil, Mexico and Rest of LATAM)
5.5.1 Latin America Hepatitis C Treatment Market, by Drug Type, 2015- 2025 (US$)
5.5.2 Latin America Hepatitis C Treatment Market, by Country, 2015- 2025 (US$)
5.6 Middle East and Africa (GCC and Rest of MEA)
5.6.1 Middle East and Africa Hepatitis C Treatment Market, by Drug Type, 2015- 2025 (US$)
5.6.2 Middle East and Africa Hepatitis C Treatment Market, by Country, 2015- 2025 (US$)
Chapter 6 Company Profiles
6.1 AbbieVie Inc.
6.2 Bristol-Myers Squibb Company
6.3 F. Hoffmann-La Roche AG
6.4 Gilead Sciences Inc.
6.5 GlaxoSmith Kline Plc.
6.6 Janssen Pharmaceuticals Inc.
6.7 Merck & Co. Inc.
6.8 Schering AG
6.9 Vertex Pharmaceuticals
TABLE 1 Market Positioning of Key Players in Global Hepatitis C Treatment Market
TABLE 2 Global Hepatitis C Treatment Market, by Drug Type, 2015 – 2025 (US$ Bn)
TABLE 3 Top 3 Countries in Global Hepatitis C Treatment Market, 2015 – 2025 (US$ Bn)
TABLE 4 Global Interferons Market in Hepatitis C Treatment, 2015 – 2025 (US$ Bn)
TABLE 5 Global Direct-Acting Antivirals (DAA) Market, 2015 – 2025 (US$ Bn)
TABLE 6 Global Hepatitis C Treatment Market, by Geography, 2015 – 2025 (US$ Bn)
TABLE 7 North America Hepatitis C Treatment Market, by Drug Type, 2015-2025 (US$ Bn)
TABLE 8 North America Hepatitis C Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 9 Europe Hepatitis C Treatment Market, by Drug Type, 2015-2025 (US$ Bn)
TABLE 10 Europe Hepatitis C Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 11 Asia Pacific Hepatitis C Treatment Market, by Drug Type, 2015-2025 (US$ Bn)
TABLE 12 Asia Pacific Hepatitis C Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 13 Latin America Hepatitis C Treatment Market, by Drug Type, 2015-2025 (US$ Bn)
TABLE 14 Latin America Hepatitis C Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 15 Middle East and Africa Hepatitis C Treatment Market, by Drug Type, 2015-2025 (US$ Bn)
TABLE 16 Middle East and Africa Hepatitis C Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 17 AbbieVie Inc.: Company Snapshot (Business Description; Financial Information; Drug Position/Portfolio; News Coverage)
TABLE 18 Bristol-Myers Squibb Company: Company Snapshot (Business Description; Financial Information; Drug Position/Portfolio; News Coverage)
TABLE 19 F. Hoffmann-La Roche AG: Company Snapshot (Business Description; Financial Information; Drug Position/Portfolio; News Coverage)
TABLE 20 Gilead Sciences Inc.: Company Snapshot (Business Description; Financial Information; Drug Position/Portfolio; News Coverage)
TABLE 21 GlaxoSmith Kline Plc.: Company Snapshot (Business Description; Financial Information; Drug Position/Portfolio; News Coverage)
TABLE 22 Janssen Pharmaceuticals Inc.: Company Snapshot (Business Description; Financial Information; Drug Position/Portfolio; News Coverage)
TABLE 23 Merck & Co. Inc.: Company Snapshot (Business Description; Financial Information; Drug Position/Portfolio; News Coverage)
TABLE 24 Schering AG: Company Snapshot (Business Description; Financial Information; Drug Position/Portfolio; News Coverage)
TABLE 25 Vertex Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Drug Position/Portfolio; News Coverage)
FIG. 1 Hepatitis C Treatment Market: Research Methodology
FIG. 2 Global Hepatitis C Treatment Market, by Drug Type, 2016 (US$ Bn)
FIG. 3 Global Hepatitis C Treatment Market Share, by Geography, 2016 (Value %)
FIG. 4 Attractive Investment Proposition: Global Hepatitis C Treatment Market, by Geography, 2016
FIG. 5 Attractive Investment Proposition: Global Hepatitis C Treatment Market, by Drug type, 2016
FIG. 6 Global Peginterferon alfa-2a Market, 2015 – 2025 (US$ Bn)
FIG. 7 Global Peginterferon alfa-2b Market, 2015 – 2025 (US$ Bn)
FIG. 8 Global Interferon alfa-2b Market, 2015 – 2025 (US$ Bn)
FIG. 9 Global Ribavirin Market, 2015 – 2025 (US$ Bn)
FIG. 10 Global Protease Inhibitor Market, 2015 – 2025 (US$ Bn)
FIG. 11 Global Polymerase Inhibitors Market, 2015 – 2025 (US$ Bn)
FIG. 12 Global Other Drugs Market, 2015 – 2025 (US$ Bn)
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)